Status:
COMPLETED
SCOT Scleroderma Treatment Alternative Registry (STAR Registry)
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Scleroderma, Systemic
Sclerosis
Eligibility:
All Genders
18-69 years
Brief Summary
The Scleroderma Cyclophosphamide Or Transplant (SCOT) Trial is a Phase II/III interventional trial comparing two treatments for early, severe scleroderma. These two interventions are high dose immunos...
Detailed Description
For multiple reasons, the SCOT investigators and the sponsor of the SCOT trial, the Division of Allergy, Immunology, and Transplantation (DAIT) of the National Institute of Allergy and Infectious Dise...
Eligibility Criteria
Inclusion
- No additional inclusion criteria
Exclusion
- No additional exclusion criteria
Key Trial Info
Start Date :
June 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2016
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT00860548
Start Date
June 1 2005
End Date
March 1 2016
Last Update
April 5 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas, Houston Medical School
Houston, Texas, United States, 77030